$HRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HERON THERAPEUTICS, INC. /DE/. Get notifications about new insider transactions in HERON THERAPEUTICS, INC. /DE/ for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.74 | 2,874 | 5,001 | 87,386 | 84.5 K to 87.4 K (+3.40 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,586 | 0 | 157,754 | 155.2 K to 157.8 K (+1.67 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,586 | 0 | 19,270 | 21.9 K to 19.3 K (-11.83 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.74 | 2,586 | 4,500 | 21,856 | 19.3 K to 21.9 K (+13.42 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 2,586 | 0 | 76,586 | 74 K to 76.6 K (+3.49 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 2,586 | 0 | 0 | 2.6 K to 0 (-100.00 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.74 | 2,586 | 4,500 | 2,586 | 0 to 2.6 K |
Aug 30 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | P | 1.50 | 10,000 | 15,000 | 155,168 | 145.2 K to 155.2 K (+6.89 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.66 | 2,700 | 4,482 | 107,799 | 105.1 K to 107.8 K (+2.57 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.66 | 2,400 | 3,984 | 54,190 | 51.8 K to 54.2 K (+4.63 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.66 | 2,400 | 3,984 | 26,931 | 24.5 K to 26.9 K (+9.78 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,400 | 0 | 145,168 | 142.8 K to 145.2 K (+1.68 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,400 | 0 | 19,270 | 21.7 K to 19.3 K (-11.08 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.66 | 2,400 | 3,984 | 21,670 | 19.3 K to 21.7 K (+12.45 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.66 | 1,800 | 2,988 | 84,512 | 82.7 K to 84.5 K (+2.18 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 2,400 | 0 | 54,698 | 52.3 K to 54.7 K (+4.59 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 2,400 | 0 | 19,302 | 21.7 K to 19.3 K (-11.06 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.66 | 2,400 | 3,984 | 21,702 | 19.3 K to 21.7 K (+12.43 %) |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.44 | 3,472 | 5,000 | 24,531 | 21.1 K to 24.5 K (+16.49 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.44 | 3,819 | 5,499 | 51,790 | 48 K to 51.8 K (+7.96 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.44 | 4,514 | 6,500 | 105,099 | 100.6 K to 105.1 K (+4.49 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.44 | 3,472 | 5,000 | 82,712 | 79.2 K to 82.7 K (+4.38 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 4,167 | 0 | 142,768 | 138.6 K to 142.8 K (+3.01 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 4,167 | 0 | 19,270 | 23.4 K to 19.3 K (-17.78 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.44 | 4,167 | 6,000 | 23,437 | 19.3 K to 23.4 K (+21.62 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 3,819 | 0 | 52,298 | 48.5 K to 52.3 K (+7.88 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 3,819 | 0 | 19,302 | 23.1 K to 19.3 K (-16.52 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.44 | 3,819 | 5,499 | 23,121 | 19.3 K to 23.1 K (+19.79 %) |
Mar 25 2005 | HRTX | HERON THERAPEUTICS ... | OCONNELL MICHAEL | Chief Executive Off ... | Grant | A | 0.01 | 50,000 | 500 | 132,200 | 82.2 K to 132.2 K (+60.83 %) |
Mar 25 2005 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Grant | A | 0.01 | 25,000 | 250 | 51,772 | 26.8 K to 51.8 K (+93.38 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.65 | 2,424 | 4,000 | 21,059 | 18.6 K to 21.1 K (+13.01 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.65 | 3,030 | 5,000 | 47,971 | 44.9 K to 48 K (+6.74 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.65 | 3,030 | 5,000 | 100,585 | 97.6 K to 100.6 K (+3.11 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.65 | 3,030 | 5,000 | 79,240 | 76.2 K to 79.2 K (+3.98 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,424 | 0 | 138,601 | 136.2 K to 138.6 K (+1.78 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,424 | 0 | 19,270 | 21.7 K to 19.3 K (-11.17 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.65 | 2,424 | 4,000 | 21,694 | 19.3 K to 21.7 K (+12.58 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 2,727 | 0 | 48,479 | 45.8 K to 48.5 K (+5.96 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 2,727 | 0 | 19,302 | 22 K to 19.3 K (-12.38 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.65 | 2,727 | 4,500 | 22,029 | 19.3 K to 22 K (+14.13 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.35 | 3,704 | 5,000 | 18,635 | 14.9 K to 18.6 K (+24.81 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.35 | 4,074 | 5,500 | 44,941 | 40.9 K to 44.9 K (+9.97 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.35 | 4,074 | 5,500 | 97,555 | 93.5 K to 97.6 K (+4.36 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.35 | 4,074 | 5,500 | 76,210 | 72.1 K to 76.2 K (+5.65 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.35 | 4,074 | 5,500 | 76,210 | 72.1 K to 76.2 K (+5.65 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 3,704 | 0 | 136,177 | 132.5 K to 136.2 K (+2.80 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 3,704 | 0 | 19,270 | 23 K to 19.3 K (-16.12 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.35 | 3,704 | 5,000 | 22,974 | 19.3 K to 23 K (+19.22 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 4,074 | 0 | 45,752 | 41.7 K to 45.8 K (+9.77 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 4,074 | 0 | 19,302 | 23.4 K to 19.3 K (-17.43 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.35 | 4,074 | 5,500 | 23,376 | 19.3 K to 23.4 K (+21.11 %) |
Sep 16 2004 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 1.25 | 120,000 | 150,000 | 120,000 | |
Sep 16 2004 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 1.25 | 120,000 | 150,000 | 120,000 | |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 3.35 | 1,194 | 4,000 | 14,931 | 13.7 K to 14.9 K (+8.69 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 3.35 | 1,493 | 5,002 | 40,867 | 39.4 K to 40.9 K (+3.79 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 3.35 | 1,493 | 5,002 | 93,481 | 92 K to 93.5 K (+1.62 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 3.35 | 1,343 | 4,499 | 72,136 | 70.8 K to 72.1 K (+1.90 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,194 | 0 | 132,473 | 131.3 K to 132.5 K (+0.91 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,194 | 0 | 19,270 | 20.5 K to 19.3 K (-5.83 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 3.35 | 1,194 | 4,000 | 20,464 | 19.3 K to 20.5 K (+6.20 %) |
Aug 26 2004 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 1.28 | 20,000 | 25,620 | 20,000 | |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 1,493 | 0 | 41,678 | 40.2 K to 41.7 K (+3.72 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 1,493 | 0 | 19,302 | 20.8 K to 19.3 K (-7.18 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 3.35 | 1,493 | 5,002 | 20,795 | 19.3 K to 20.8 K (+7.73 %) |
Jun 17 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 40,185 | 0 | 40,185 | 0 to 40.2 K |
Jun 17 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 40,185 | 0 | 19,302 | 59.5 K to 19.3 K (-67.55 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 1.21 | 10,000 | 12,100 | 0 | |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 10,000 | 0 | 131,279 | 121.3 K to 131.3 K (+8.25 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 10,000 | 0 | 19,270 | 29.3 K to 19.3 K (-34.16 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 1.21 | 10,000 | 12,100 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 1.21 | 10,000 | 12,100 | 0 | |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 10,000 | 0 | 131,279 | 121.3 K to 131.3 K (+8.25 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 10,000 | 0 | 19,270 | 29.3 K to 19.3 K (-34.16 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 1.21 | 10,000 | 12,100 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,502 | 0 | 121,279 | 119.8 K to 121.3 K (+1.25 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,633 | 0 | 119,777 | 118.1 K to 119.8 K (+1.38 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,502 | 0 | 19,270 | 20.8 K to 19.3 K (-7.23 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,633 | 0 | 20,772 | 22.4 K to 20.8 K (-7.29 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 3.33 | 1,201 | 3,999 | 13,737 | 12.5 K to 13.7 K (+9.58 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 2.45 | 1,633 | 4,001 | 12,536 | 10.9 K to 12.5 K (+14.98 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 3.33 | 1,351 | 4,499 | 39,374 | 38 K to 39.4 K (+3.55 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 2.45 | 2,041 | 5,000 | 38,023 | 36 K to 38 K (+5.67 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 3.33 | 1,802 | 6,001 | 91,988 | 90.2 K to 92 K (+2.00 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 2.45 | 2,041 | 5,000 | 90,186 | 88.1 K to 90.2 K (+2.32 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 3.33 | 1,802 | 6,001 | 91,988 | 90.2 K to 92 K (+2.00 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 2.45 | 2,041 | 5,000 | 90,186 | 88.1 K to 90.2 K (+2.32 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 3.33 | 1,652 | 5,501 | 70,793 | 69.1 K to 70.8 K (+2.39 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 2.45 | 1,837 | 4,501 | 69,141 | 67.3 K to 69.1 K (+2.73 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 3.33 | 1,502 | 5,002 | 22,405 | 20.9 K to 22.4 K (+7.19 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.45 | 1,633 | 4,001 | 20,903 | 19.3 K to 20.9 K (+8.47 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 3.33 | 1,502 | 5,002 | 59,487 | 58 K to 59.5 K (+2.59 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 2.45 | 2,041 | 5,000 | 57,985 | 55.9 K to 58 K (+3.65 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 2.95 | 10,000 | 29,500 | 0 | |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 2.34 | 10,000 | 23,400 | 0 | |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 20,000 | 0 | 118,144 | 98.1 K to 118.1 K (+20.38 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 20,000 | 0 | 19,270 | 39.3 K to 19.3 K (-50.93 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 2.34 | 10,000 | 23,400 | 39,270 | 29.3 K to 39.3 K (+34.16 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 2.95 | 10,000 | 29,500 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
Jan 16 2004 | HRTX | HERON THERAPEUTICS ... | OCONNELL MICHAEL | Chief Executive Off ... | Option Exercise | A | 2.45 | 25,000 | 61,250 | 25,000 | |
Jan 16 2004 | HRTX | HERON THERAPEUTICS ... | OCONNELL MICHAEL | Chief Executive Off ... | Option Exercise | A | 2.45 | 25,000 | 61,250 | 25,000 | |
Jan 16 2004 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 2.45 | 25,000 | 61,250 | 25,000 | |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 2.23 | 1,794 | 4,001 | 10,903 | 9.1 K to 10.9 K (+19.69 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 2.23 | 1,794 | 4,001 | 10,903 | 9.1 K to 10.9 K (+19.69 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 2.23 | 1,570 | 3,501 | 35,982 | 34.4 K to 36 K (+4.56 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 2.23 | 2,466 | 5,499 | 88,145 | 85.7 K to 88.1 K (+2.88 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 2.23 | 1,794 | 4,001 | 55,944 | 54.2 K to 55.9 K (+3.31 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 2.23 | 2,466 | 5,499 | 195,304 | 192.8 K to 195.3 K (+1.28 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 2.23 | 2,466 | 5,499 | 195,304 | 192.8 K to 195.3 K (+1.28 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 2.23 | 1,794 | 4,001 | 55,944 | 54.2 K to 55.9 K (+3.31 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 2.23 | 2,466 | 5,499 | 195,304 | 192.8 K to 195.3 K (+1.28 %) |
Oct 09 2003 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.23 | 1,794 | 4,001 | 98,144 | 96.4 K to 98.1 K (+1.86 %) |